Page last updated: 2024-10-18

dalteparin and Cardiac Output, Low

dalteparin has been researched along with Cardiac Output, Low in 2 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.

Research Excerpts

ExcerptRelevanceReference
"This was a randomized, standard treatment-controlled, 2-center pilot trial of 102 patients (52 receiving adjunctive therapy with enoxaparin at a dosage of 1."2.72Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: one-year follow-up results of the randomized trial. ( Lekston, A; Nowak, J; Nowalany-Kozielska, E; Poloński, L; Szyguła-Jurkiewicz, B; Trzeciak, P; Wilczek, K; Wodniecki, J; Wojnicz, R; Zembala, M, 2006)
"Venous thromboembolism was previously regarded as a surgical problem, but occurs at least as frequently among medical patients."1.32Venous thromboembolic risk and prevention in acute medical illness. ( Hampton, KK, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hampton, KK1
Wojnicz, R1
Nowak, J1
Szyguła-Jurkiewicz, B1
Wilczek, K1
Lekston, A1
Trzeciak, P1
Nowalany-Kozielska, E1
Zembala, M1
Wodniecki, J1
Poloński, L1

Trials

1 trial available for dalteparin and Cardiac Output, Low

ArticleYear
Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: one-year follow-up results of the randomized trial.
    American heart journal, 2006, Volume: 152, Issue:4

    Topics: Adult; Anticoagulants; Cardiac Output, Low; Cardiomyopathy, Dilated; Cardiovascular Agents; Chronic

2006

Other Studies

1 other study available for dalteparin and Cardiac Output, Low

ArticleYear
Venous thromboembolic risk and prevention in acute medical illness.
    International journal of clinical practice, 2003, Volume: 57, Issue:5

    Topics: Acute Disease; Aged; Anticoagulants; Cardiac Output, Low; Enoxaparin; Female; Hospitalization; Human

2003